Lawsuit Over Xarelto Death in High-Risk A-Fib Patient

Allen Cleland took Xarelto to treat his atrial fibrillation (AF) for less than one year before his untimely death from an intracranial brain bleed, which could not be treated by doctors due to the lack of antidote for the blood-thinning medication. Now, his family has filed a lawsuit against the drugmakers Johnson & Johnson and Bayer Healthcare for fraudulently misrepresenting the safety of the drug, which unlike its older, less hazardous counterpart warfarin, has no reversal agent in the event of bleeding. While Xarelto is dangerous for all users due to its severe bleeding risks, several recent studies have drawn particular attention to its danger in AF patients, especially when combined with the use of digoxin or dialysis treatments.

Real Time Analytics